WO2015023927A3 - Composition and method for detection of nanomaterials - Google Patents

Composition and method for detection of nanomaterials Download PDF

Info

Publication number
WO2015023927A3
WO2015023927A3 PCT/US2014/051227 US2014051227W WO2015023927A3 WO 2015023927 A3 WO2015023927 A3 WO 2015023927A3 US 2014051227 W US2014051227 W US 2014051227W WO 2015023927 A3 WO2015023927 A3 WO 2015023927A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
nanomaterials
detection
nanomaterial
abundance
Prior art date
Application number
PCT/US2014/051227
Other languages
French (fr)
Other versions
WO2015023927A2 (en
Inventor
Lisa Delouise
Supriya RAVICHANDRAN
Mark Sullivan
Original Assignee
University Of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Rochester filed Critical University Of Rochester
Publication of WO2015023927A2 publication Critical patent/WO2015023927A2/en
Publication of WO2015023927A3 publication Critical patent/WO2015023927A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Abstract

The present invention provides compositions and methods for detecting the presence, location, or abundance of a nanomaterial. In certain embodiments, the composition of the invention is identified using a screening method utilizing phage display of a library of test compounds.
PCT/US2014/051227 2013-08-16 2014-08-15 Composition and method for detection of nanomaterials WO2015023927A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361866716P 2013-08-16 2013-08-16
US61/866,716 2013-08-16

Publications (2)

Publication Number Publication Date
WO2015023927A2 WO2015023927A2 (en) 2015-02-19
WO2015023927A3 true WO2015023927A3 (en) 2015-04-09

Family

ID=52468817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/051227 WO2015023927A2 (en) 2013-08-16 2014-08-15 Composition and method for detection of nanomaterials

Country Status (1)

Country Link
WO (1) WO2015023927A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064508A1 (en) * 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
US20070063154A1 (en) * 2005-02-02 2007-03-22 Wei Chen Energy-transfer nanocomposite materials and methods of making and using same
US20100117029A1 (en) * 2007-04-30 2010-05-13 Ying Jackie Y Forming crosslinked-glutathione on nanostructure
US20100255056A1 (en) * 2009-02-12 2010-10-07 Steven Jacobs Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
US20120149061A1 (en) * 2009-01-12 2012-06-14 Stagliano Nancy E Modified Antibody Compositions, Methods of Making and Using Thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064508A1 (en) * 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
US20070063154A1 (en) * 2005-02-02 2007-03-22 Wei Chen Energy-transfer nanocomposite materials and methods of making and using same
US20100117029A1 (en) * 2007-04-30 2010-05-13 Ying Jackie Y Forming crosslinked-glutathione on nanostructure
US20120149061A1 (en) * 2009-01-12 2012-06-14 Stagliano Nancy E Modified Antibody Compositions, Methods of Making and Using Thereof
US20100255056A1 (en) * 2009-02-12 2010-10-07 Steven Jacobs Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK 9 March 2003 (2003-03-09), "Synthetic construct clone 12 recombinant immunoglobulin single chain variable fragment mRNA, partial cds", accession no. Y143559 *

Also Published As

Publication number Publication date
WO2015023927A2 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
IL283341B (en) Systems and methods for detection and quantification of analytes
EP3090058A4 (en) Systems, compositions and methods for detecting and analyzing micro-rna profiles from a biological sample
EP3014654A4 (en) System and method for defect detection and photoluminescence measurement of a sample
EP3014063A4 (en) System and method for formation detection and evaluation
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
BR112015031099A2 (en) dust suppressor
IL255659A (en) Methods and compositions for diagnosing or detecting lung cancers
HRP20190055T1 (en) Detection methods for sample species origin
WO2014165487A3 (en) Cement evaluation
EP3140960A4 (en) Methods, systems, and computer readable media for providing fuzz testing functionality
PL3273227T3 (en) Method for analysing a sample comprising at least a first and a second scale inhibitor
EP2972348A4 (en) Methods of detecting donor-specific antibodies and systems for practicing the same
EP2951852A4 (en) Systems and methods for analyzing an extracted sample
EP3015849A4 (en) Sizing defect detection system and sizing defect detection method
WO2014172390A3 (en) Methods for detecting cancer metastasis
EP2836823A4 (en) Systems and methods for sample inspection and review
EP3068399A4 (en) Compositions and methods for assessing gut function
EP3076152A4 (en) Corrosion reagent for detecting steel macrostructure and defect, and detection method
MX2016001719A (en) Methods and kits for predicting the risk of having a cardiovascular disease or event.
EP3370064A4 (en) Reagent and method for measuring thrombin-antithrombin complex
HK1244537A1 (en) Reagent and method for assaying thrombin-antithrombin complex
EP3004375A4 (en) Protease-responsive peptide biosensors and methods for analyte detection
WO2015023927A3 (en) Composition and method for detection of nanomaterials
LU92447B1 (en) Method and specimen for testing tire noise
WO2013188623A9 (en) Methods for predicting cardiotoxicity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14835911

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14835911

Country of ref document: EP

Kind code of ref document: A2